Being a sponsor or an exhibitor at the Community Oncology Conference is a fantastic way to reach nearly 1,800+ attendees that include oncologists/hematologists, practice managers, nurses, payers, employers, advocacy groups, industry stakeholders and more. By supporting the 2023 Community Oncology Conference as an exhibitor or sponsor, you are helping community oncology shape a future where all Americans have access to local, affordable, high-quality cancer care.
There are many sponsorship opportunities available, including exhibiting, hosting an educational advisory board, supporting social functions, conference materials and giveaways, and much more. We cannot do this without the ongoing support of the community.
Interested in being an Exhibitor or Sponsor? Read our Conference Prospectus. Then email Mary Kruczynski to get started! We can’t wait to partner with you at this years Community Oncology Conference.
Executive Platinum Exhibitors
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Cardinal Health
Daiichi-Sankyo
At Daiichi Sankyo, we create essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those most in need. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow with great care and unwavering dedication. We rely on reason, ingenuity, perseverance and empathy to make bold strides in oncology.
Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves.
Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world. Please visit www.daiichisankyo.us.
Flatiron Health®
Flatiron Health is a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.
Follow Us
Genentech
For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
We are headquartered in South San Francisco, California.
Incyte
Follow Us
Janssen
At Janssen, we’re creating a future where disease is a thing of the past.We’re thePharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access within genuity, and healing hopelessness with heart.
Follow Us
McKesson
Follow McKesson
Follow The US Oncology Network
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Patient Point
PatientPoint® is the patient engagement platform more providers trust. From patient acquisition to in-office and hospital engagement to remote care, our innovative, tech-enabled solutions deliver highly relevant, personalized health experiences across the entire patient journey. More than 140k healthcare providers trust PatientPoint to help them increase practice efficiencies, enhance the patient experience and improve outcomes. See how we can do the same for you. Learn more at patientpoint.com/coa.
Follow Us
Pharmacyclics
Regeneron
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Follow Us
Gold Exhibitors
Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. Adaptive’s goal is to develop and commercialize immune-driven diagnostics and therapeutics tailored to each individual patient.
Follow Us
AmerisourceBergen (AB)
AmerisourceBergen (AB) empowers physician practices to deliver quality patient care today and prepare for the challenges of tomorrow. Through our ION Oncology Specialty GPO Network and Oncology Supply specialty distribution, along with our portfolio of integrated solutions and services, we are a unified team of specialty practice partners, committed to building on our legacy of best-in-class service with meaningful innovation that supports our customers as they improve communities through patient-centric care.
Follow Us
Astellas
Astellas –
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Astellas Oncology –
Astellas Oncology is committed to elevating the standard of cancer care. We focus on developing innovative, targeted therapies for hard-to-treat cancers with limited treatment options, which is where we see the greatest opportunity to help people living with cancer.
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 9,000+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline with the launch of the OncoExTraTM and RiskguardTM tests to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
Eisai Co., Ltd.
At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Follow Us
Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. We are a leading provider of generic, medications with 100-year history of delivering innovate therapies that are safe, efficient, and affordable. That’s how we bring confidence within reach.
Follow Us
GSK
Follow Us
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
Follow Us
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer.
We are a platform of the nation’s leading independent oncology practices consisting of 940+ providers, practicing at 300+ sites of care and serving over 520,000 patients per year. We are bringing the latest cancer research and treatment options to patients close to home. OneOncology invests in practices to help them grow within their local markets, diversify across multiple specialties, apply data insights, and leverage technology to strengthen performance.
Join the partnership. Drive the future.
Follow Us
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Pfizer Oncology
Follow Us
Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to help improve people’s lives. We are working to advance potentially transformative therapies to help people with cancer. Our current work and research focuses on lung, prostate, multiple myeloma and other blood cancers. We take bold steps every day to advance our pipeline and seek solutions that help address critical gaps in care across a variety of difficult-to-treat cancers. Our oncology strategy focuses on developing a portfolio of high-quality assets that we believe will have the potential to improve oncology care.
Silver Exhibitors
American Oncology Network, LLC (AON)
AON serves its expanding network of partner practices by providing over 36 years of proven practice management expertise, dedicated end-to-end administrative support and access to an extensive array of centralized ancillary support services.
AON was recognized on the Inc. 5000 in 2022 as one of the fastest-growing private companies in the nation. Securing the No. 107 overall and No. 8 in the health services category positions, AON continues to grow and serve community oncology practices across the United States.
Follow Us
American Regent, Inc.
American Regent, Inc., a Daiichi Sankyo Group company, is a top-10, US-based injectable drug manufacturer. For over 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers and for more than 20 years, we have been a leader in IV iron therapy.
Follow Us
Amgen
Follow Us
Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
Follow Us
CTI Biopharma
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in Seattle, Washington.
Follow Us
Foundation Medicine
Follow Us
EMD Serono
EMD Serono-the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada-aspires to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. The business is imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono’s global roots go back more than 350 years with Merck KGaA,Darmstadt, Germany. Today, the business has more than 1,000 employees around the country with commercial, clinical and research operations in Massachusetts.
Follow Us
Florida Cancer Specialists
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past five years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with FCS participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
Follow Us
Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
Follow Us
Illumina
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data. Through collaborative innovation, Illumina is fueling ground breaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
Follow Us
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Novartis
Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership inR&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 106,000people of more than 140 nationalities work together to bring Novartis products to nearly 800million people around the worldFind out more at www.novartis.com
RxVantage
RxVantage is transforming the way physicians and their practice teams make healthcare connections that elevate the practice of medicine. The only all-in-one provider preferred engagement platform of its kind, RxVantage intelligently connects healthcare providers with resources including the precise life sciences experts that they need, when they need it and in a manner that fits seamlessly into their workflow.
Follow Us
Servier Pharmaceuticals
Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio and seeking acquisitions, licensing deals and partnerships.
With our commercial and scientific expertise, global reach and commitment to clinical excellence, Servier Pharmaceuticals is dedicated to bringing the promise of tomorrow to the patients that we serve.
Follow Us
Stemline Therapeutics
Unlimited Systems
Unlimited Systems provides a platform for a wide range of specialty healthcare practices seeking measurable increases in staff productivity, cash flow, and revenue with their feature product Unlimited Financials. Unlimited Financials is a full-featured revenue cycle platform with detailed analytics and task-driven workflows from start to finish. Specialty healthcare practices using Unlimited Financials can be confident that they will achieve peak financial performance.
Follow Us
Viatris
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
Follow Us
Bronze Exhibitors
AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious healthissues today and address the medical challenges of tomorrow. We strive to have a remarkableimpact on people’s lives across several keytherapeutic areas: immunology, oncology,neuroscience, eye care, virology, women’s health and gastroenterology, in addition to productsand services across its Allergan Aesthetics portfolio. For more information about AbbVie, pleasevisit us at www.abbvie.com.
Follow Us
ADMA Biologics
ADMA Biologics is an end-to-end commercial biopharmaceutical company committed to manufacturing, marketing, and developing specialty plasma-derived products for the prevention and treatment of infectious diseases in the immune compromised and other patients at risk for infection. Our devotion to these underserved populations fuels us, and our hands-on approach to production and development sets us apart.
Follow Us
Apellis
At Apellis, we are committed to developing therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system.
Follow Us
The Association for Value-Based Cancer Care
The Association for Value-Based Cancer Care (AVBCC) is a 501(c)(6) organization dedicated to the education and exchange of knowledge among all stakeholders in the cancer care ecosystem responsible for patient care, to ensure optimal care is delivered to patients with cancer.The mission of AVBCC is to provide a forum for payers, providers, and the entire oncology team enter into conversations and evaluate value in terms of impact, quality, and cost on patient care and outcomes.
AVEO Oncology
Aveo is an oncology focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients.
Follow Us
Bayer
Bayer is committed to delivering science for a better life by advancing a portfolio of innovative treatments. The oncology franchise at Bayer includes six marketed products and several other assets in various stages of clinical development. Together, these products reflect the company’s approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.
Follow Us
Blueprint Medicines
Blueprint Medicines is a global precision therapy company that aims to invent transformative medicines for people with cancer and blood disorders. Applying an approach that is both precise and agile, we seek to create medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate our scientific innovation into a broad pipeline of important approved and investigational precision therapies aimed at addressed difficult-to-treat cancers and blood disorders. Today, we are delivering our approved medicines to patients in the United States, Europe and in other geographies ourselves or through our partners. In addition, we are globally advancing multiple programs for systemic mastocytosis, lung cancer, breast cancer, and other genomically defined cancers, and cancer immunotherapy.
Follow Us
Boehringer Ingelheim
Follow Us
Canopy
Follow Us
Care Access
Care Access is on a mission to increase access to clinical trials for patients who have traditionally been left out of the research process. Our innovative approach enables community-based physicians to engage in research studies while focusing on patient care. Whether they are seasoned clinical researchers or new to the field, we partner with community-based physicians interested in incorporating research into their practice.
Follow Us
Coherus Biosciences
Coherus BioSciences is a leading global biologics platform company focused on delivering high-quality biosimilar therapeutics that can expand patient access to important, cost-effective medicines and delivering significant savings to the US Healthcare system. Coherus was founded a decade ago to provide the highest quality biosimilar treatments to patients. We are proud to now be expanding our legacy—to build on our success with biosimilars and to focus our core strengths on immuno-oncology. For additional information, please visit www.coherus.com.
Follow Us
CuraScript SD
CuraScript SD provides integrated delivery solutions for the safe & efficient distribution of specialty pharmaceuticals & associated medical supplies. We’ve been caring for those who care for more than a quarter of a century by supplying biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products to a wide range of medical providers.
Follow Us
Eagle Pharmaceuticals
Follow Us
Exelixis
Follow Us
G1 Therapeutics
G1 is committed to improving the lives of those impacted by cancer. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first product.
Follow Us
Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
Follow Us
Guardant Health
Follow Us
Heron Therapeutics, Inc.
Imagia Canexia Health
Only a small percentage of cancer patients receive genetic biomarker testing that could match them with targeted treatments demonstrated to improve outcomes. At Imagia Canexia Health, we pair the latest advances in oncology with machine learning to provide oncology professionals with the insights needed to inform targeted treatment decisions. Together, we’re making precision oncology more accessible.
Follow Us
Immunocore
We are a pioneering, commercial-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infectious and autoimmune diseases.
Follow Us
ImmunoGen
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOW™. Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Follow Us
Integra Connect
Integra Connect is a value-based, precision medicine company that leads the industry in RWD and analytics capabilities for oncology. With clinical and claims data, deep expertise and sophisticated technologies, it enables providers, payers, and life sciences companies to improve outcomes, decision-making, performance, and research endeavors.
Follow Us
Invitae
Invitae’s mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Our goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time and lower prices. Visit www.invitae.com.
Follow Us
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies dedicated to the discovery, development, and commercialization of novel first-in-class drugs for the treatment of cancer and other diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. The company was founded in 2008 with a vision of pioneering a potentially new approach to treating patients with certain blood cancers.
Labcorp
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives.
Follow Us
Lantheus
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radio therapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com.
Follow Us
MacroGenics
MacroGenics is a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company’s flagship product for the treatment of HER2+ metastatic breast cancer was approved by the US Food and Drug Administration in December 2020. MacroGenics generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics’ technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.
Myriad
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. Fast Company named Myriad among the World’s Most Innovative Companies for 2022. For more information, visit www.myriad.com.
Follow Us
Ontada
Ontada® is an oncology real-world data and evidence, clinical education and provider technology business dedicated to transforming the fight against cancer. Part of McKesson Corporation, we support science through our data, technology and channels, which accelerate innovation for life science companies, support the education of community oncology providers and advance patient care. Together with our partners, we improve the lives of cancer patients. For more information, visit ontada.com or follow @OntadaOncology.
Follow Us
Paxman
As Healthcare Professionals, you understand the extent to which CIA can compromise a patient’s quality of life, often negatively impacting on body image, self-esteem and depriving patients of their privacy. Sometimes, the prospect of CIA can cause patients to refuse treatment.
The Paxman Scalp Cooling System, reduces hair loss in cancer patients undergoing chemotherapy. Paxman have grown to become the world’s leading manufacturer and supplier of scalp cooling equipment.
Proven to be an effective way of combatting CIA, scalp cooling can result in a high level of retention or completely preserve the hair. Scalp cooling has also been shown in studies to encourage better and faster hair regrowth following completion of chemotherapy treatment. For patients, this means the opportunity to regain some control, maintain privacy and encourage a positive attitude towards treatment.
Investing in scientific testing and development has allowed Paxman to attain the highest levels of technical precision and clinical efficacy. Clinical trials, research and health service dialogue this remains ongoing.
NCCN® Clinical Practice Guidelines in oncology (Version 1.2019) recommend scalp cooling as a category 2A treatment option to reduce the incidence of CIA for patients with invasive breast cancer receiving chemotherapy.
US Centers for Medicare & Medicaid Services (CMS) has reassigned payment for scalp cooling for Medicare claims filed using CPT code 0662T. This treatment has been reassigned to New Technology APC 1520 effective January 1, 2022.
Let’s work together to chase zero hair loss during chemotherapy and provide patients with a sense of normalcy during one of the most difficult times of their lives.
Visit www.paxmanscalpcooling.com for detailed clinical information, www.coldcap.com for our patient guide or e-mail us at HCP@paxmanUSA.com.
Follow Us
Pharmacosmos Therapeutics Inc.
Pharmacosmos is a dedicated, family-owned company founded in 1965, with a global reach that specializes in innovative treatments for patients with from iron deficiency anemia. Pharmacosmos Therapeutics Inc was established in 2019 to bring those innovative treatments for iron deficiency anemia to the United States.
Follow Us
PharmaEssentia
PharmaEssentia Corporation, based in Taipei, Taiwan, is a rapidly growing biopharmaceutical innovator. Leveraging deep expertise and proven scientific principles, the company aims to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one approved product and a diversifying pipeline. Founded in 2003, the company is now expanding its global presence with operations the U.S., Japan, China and Korea. Visit our website to learn more.
Follow Us
Puma Biotechnology, Inc.
Rigel Pharmaceuticals
Rigel Pharmaceuticals is a biotechnology company dedicated to improving the lives of patients through the development and commercialization of novel small molecule drugs, focused on immune and hematologic disorders, cancer, and rare diseases.
Rigel has 2 FDA approved products:
-TAVALISSE® (fostamatinib disodium hexahydrate) tablets was approved in 2018.Please visit www.TAVALISSEhcp.com to see the full Prescribing Information and learn more.
-REZLIDHIATM(olutasidenib) capsules was approved in 2022. Please visitwww.REZLIDHIAhcp.comto see the Full Prescribing Information, including BoxedWARNING to learn more
Follow Us
SamaCare
SamaCare’s free prior authorization management platform aims to alleviate one of the biggest administrative burdens in healthcare today – prior authorization management – by unifying and automating prior authorization submissions, tracking, and follow-up across all payers and physician-administered drugs. Thereby reducing the administrative workload and preventing human errors caused by manual data entry between systems, ultimately reducing staff burnout and facilitating a better patient experience.
Follow Us
SCiO
SCIO’s Consulting and Auditing Services not only identify the gaps in a practice’s revenue cycle, but SCIO will correct the errors and refile the corrected claims on behalf of your practice. Our Revenue Recovery Audits are contingency based, so there are no upfront fees and we only collect a percentage of the recovered revenue recognized in the audit that your practice wasn’t aware was missing.
Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. For additional information on Spectrum please visit www.sppirx.com.
Follow Us
Taiho Oncology Inc.
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of antimetabolic and selectively targeted anti-cancer agents are led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com
Follow Us
Takeda Oncology
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. We ensure a tight connection from research to development to commercialization and rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to patients. Our demonstrated leadership in the treatment of hematologic cancers and solid tumors combined with cutting-edge science through multiple platforms, partnerships and therapeutic approaches enable us to bring novel medicines to patients worldwide.
For more information, visit www.takedaoncology.com.
Follow Us
Willow Risk Advisors, Inc
Willow Risk Advisors is a nationally recognized professional liability (malpractice) insurance brokerage that is licensed in all 50 states. Willow Risk is the administrator of the ORION Oncology Malpractice Insurance Program. The program is designed around the specialty of Oncology.
Follow Us
Thank you
Amgen
Follow Us
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Canopy
The first Intelligent Care Platform for oncology, Canopy provides practices and life sciences organizations with intelligent solutions for proactive, outcome-based care. Canopy’s comprehensive and EMR-integrated suite of products includes ePRO-based Patient Monitoring (ePROs), Oral Oncolytics solutions, clinical workflow and patient engagement tools, as well as automated billing, reimbursement capture, and advanced analytics.
Follow Us
CardinalHealth
CureMD
Our award-winning solutions simplify decision making, streamline operations, and ensure compliance with industry standards and best practices; ultimately saving time and effort to maximize value and returns.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
Florida Cancer Specialists
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past five years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with FCS participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
Follow Us
Janssen
At Janssen, we’re creating a future where disease is a thing of the past.We’re thePharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access within genuity, and healing hopelessness with heart.
Follow Us
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
McKesson
Follow McKesson
Follow The US Oncology Network
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Follow Us
Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to help improve people’s lives. We are working to advance potentially transformative therapies to help people with cancer. Our current work and research focuses on lung, prostate, multiple myeloma and other blood cancers. We take bold steps every day to advance our pipeline and seek solutions that help address critical gaps in care across a variety of difficult-to-treat cancers. Our oncology strategy focuses on developing a portfolio of high-quality assets that we believe will have the potential to improve oncology care.
Thyme Care
Thyme Care is an oncology population management platform that provides personalized, clinically coordinated care navigation to individuals with cancer. Our multidisciplinary care team, which includes oncology nurses, and digital care delivery platform serve as an extension of the practices we work with, unlocking practice staff efficiency and paving the way for their success in value-based care models. We partner with community oncology practices to enhance care coordination and ensure timely patient access to high-value oncologists, and currently have 220oncology provider partners. Our unique approach allows us to extend beyond the four walls of the practice, improving patient experience and outcomes, enhancing team efficiency and aligning incentives across stakeholders.
Follow Us
